Anti-Glypican 1/ GPC1 抗体 [EPR19285] (ab199343)
![Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)](https://www.abcam.co.jp/ps/products/199/ab199343/Images/ab199343-266589-anti-glypican-1-gpc1-antibody-epr19285-western-blot.jpg "Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)")
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR19285] to Glypican 1/ GPC1
- Suitable for: Flow Cyt (Intra), WB, ICC/IF
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-Glypican 1/ GPC1 antibody [EPR19285]
Glypican 1/ GPC1 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR19285] to Glypican 1/ GPC1 -
由来種
Rabbit -
アプリケーション
適用あり: Flow Cyt (Intra), WB, ICC/IFmore details -
種交差性
交差種: Human -
免疫原
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ･コントロール
- WB: MDA-MB-231, MOLT-4, HepG2, K562, SH-SY5Y and MCF7 whole cell lysates; Human fetal kidney, colon and fetal spleen lysates. ICC/IF: MCF7 and MDA-MB-231 cells. Flow Cyt (intra): MDA-MB-231 cells.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading... -
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR19285 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab199343の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| Flow Cyt (Intra) |
1/60.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. |
|
| WB |
1/1000. Detects a band of approximately 55 kDa (predicted molecular weight: 61 kDa).
|
|
| ICC/IF |
1/500.
|
| 特記事項 |
|---|
|
Flow Cyt (Intra)
1/60. ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. |
|
WB
1/1000. Detects a band of approximately 55 kDa (predicted molecular weight: 61 kDa). |
|
ICC/IF
1/500. |
ターゲット情報
-
機能
Cell surface proteoglycan that bears heparan sulfate. -
配列類似性
Belongs to the glypican family. -
翻訳後修飾
This cell-associated glypican is further processed to give rise to a medium-released species. -
細胞内局在
Cell membrane and Secreted > extracellular space. - Information by UniProt
-
参照データベース
- Entrez Gene: 2817 Human
- Omim: 600395 Human
- SwissProt: P35052 Human
- Unigene: 328232 Human
-
別名
- FLJ38078 antibody
- glypican antibody
- Glypican proteoglycan 1 antibody
see all
画像
-
Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)All lanes : Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343) at 1/1000 dilution
Lane 1 : MDA-MB-231 (Human breast adenocarcinoma cell line) whole cell lysate
Lane 2 : MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate
Lane 3 : HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate
Lane 4 : K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate
Lane 5 : SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate
Lane 6 : MCF7 (Human breast adenocarcinoma cell line) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 61 kDa
Additional bands at: 55 kDa (possible post-translational modification)
Exposure time: 3 secondsBlocking/Dilution buffer: 5% NFDM/TBST.
The molecular weight observed is consistent with the literature (PMID: 9802880).
-
![Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)](https://www.abcam.co.jp/ps/products/199/ab199343/Images/ab199343-266586-anti-glypican-1-gpc1-antibody-epr19285-immunofluorescence.jpg)
Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized MDA-MB-231 (Human breast adenocarcinoma cell line) cells labeling Glypican 1/ GPC1 with ab199343 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing membrane associated and cytoplasmic staining on MDA-MB-231 cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is ab150077 at 1/1000 dilution.
-
![Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)](https://www.abcam.co.jp/ps/products/199/ab199343/Images/ab199343-266587-anti-glypican-1-gpc1-antibody-epr19285-immunofluorescence.jpg)
Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized MCF7 (Human breast adenocarcinoma cell line) cells labeling Glypican 1/ GPC1 with ab199343 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing cytoplasmic staining on MCF7 cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).
Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is ab150077 at 1/1000 dilution.
-
![Flow Cytometry (Intracellular) - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)](https://www.abcam.co.jp/ps/products/199/ab199343/Images/ab199343-266585-anti-glypican-1-gpc1-antibody-epr19285-flow-cytometry.jpg)
Flow Cytometry (Intracellular) - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed MDA-MB-231 (Human breast adenocarcinoma cell line) cells labeling Glypican 1/ GPC1 with ab199343 at 1/60 dilution (red) compared with a RabbitIgG,monoclonal[EPR25A]-Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
-
![Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)](https://www.abcam.co.jp/ps/products/199/ab199343/Images/ab199343-266588-anti-glypican-1-gpc1-antibody-epr19285-western-blot.jpg)
Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)All lanes : Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343) at 1/1000 dilution
Lane 1 : Human fetal kidney lysate
Lane 2 : Human colon lysate
Lane 3 : Human fetal spleen lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 61 kDa
Observed band size: 55 kDa why is the actual band size different from the predicted?Blocking/Dilution buffer: 5% NFDM/TBST.
Exposure time: Lane 1: 5 seconds; Lanes 2 and 3: 10 seconds.
-
![Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)](https://www.abcam.co.jp/ps/products/199/ab199343/Images/ab199343-7-benefits-of-recombinant-antibodies.png)
Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343)
プロトコール
データシートおよび資料
-
Datasheet download
Certificate of Compliance
参考文献 (4)
ab199343 は 4 報の論文で使用されています。
- Chen G et al. High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma. Oncol Lett 20:197 (2020). PubMed: 32963603
- Risha Y et al. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers. Sci Rep 10:13572 (2020). PubMed: 32782317
- Qiu W et al. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer. Int J Nanomedicine 13:6809-6827 (2018). PubMed: 30425490
- Li G et al. Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer. Glycoconj J N/A:N/A (2017). PubMed: 28822024
